SYNTHESIS AND INVITRO BIOLOGICAL PROFILE OF ALL 4 ISOMERS OF THE POTENT MUSCARINIC AGONIST 3-(3-METHYL-1,2,4-OXADIAZOL-5-YL)-1-AZABICYCLO[2.2.1]HEPTANE

被引:18
作者
SHOWELL, GA
BAKER, R
DAVIS, J
HARGREAVES, R
FREEDMAN, SB
HOOGSTEEN, K
PATEL, S
SNOW, RJ
机构
[1] MERCK SHARP & DOHME LTD,NEUROSCI RES CTR,DEPT BIOCHEM,HARLOW CM20 2QR,ESSEX,ENGLAND
[2] MERCK SHARP & DOHME LTD,NEUROSCI RES CTR,DEPT PHARMACOL,HARLOW CM20 2QR,ESSEX,ENGLAND
[3] MERCK SHARP & DOHME LTD,RAHWAY,NJ 07065
关键词
D O I
10.1021/jm00083a016
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The four stereoisomers of the muscarinic agonist 7 have been synthesized from enantiomerically pure exo-azanorbornane esters (13a,b). The esters were obtained in optically active form by separation of the carboxamide diastereomers 12a,b, formed from the borane complex of exo-azanorbornane-3-carboxylate 10 and a chiral amine auxilliary. Using the known chirality of (R)-alpha-methylbenzylamine, an X-ray analysis was accomplished on 12a in order to determine the absolute configuration of the azanorbornane C4 chiral center. Each of the chiral esters 13a,b was separately transformed into the oxadiazoles with concomitant epimerization at C3 of the azanorbornane ring to afford the thermodynamic equilibrium mixture of isomers. Chromatographic separation followed by analysis of each isomer by NMR and GC allowed the absolute stereochemistry of all four isomers of 7 to be confirmed. Full biological evaluation in biochemical and pharmacological assays revealed that the 3R,4R isomer was the most active on receptor binding studies and the most potent on the pharmacological preparations, showing a 50-fold increase in potency at the M2 and M3 sites compared to M1.
引用
收藏
页码:911 / 916
页数:6
相关论文
共 17 条
  • [1] CAINE ED, 1980, NEW ENGL J MED, V303, P585
  • [2] PHYSOSTIGMINE AND ARECOLINE - EFFECTS OF INTRAVENOUS INFUSIONS IN ALZHEIMER PRESENILE-DEMENTIA
    CHRISTIE, JE
    SHERING, A
    FERGUSON, J
    GLEN, AIM
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1981, 138 (JAN) : 46 - 50
  • [3] 3-DIMENSIONAL MODELING OF G-PROTEIN-LINKED RECEPTORS
    FINDLAY, J
    ELIOPOULOS, E
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (12) : 492 - &
  • [4] RELATIVE AFFINITIES OF DRUGS ACTING AT CHOLINOCEPTORS IN DISPLACING AGONIST AND ANTAGONIST RADIOLIGANDS - THE NMS OXO-M RATIO AS AN INDEX OF EFFICACY AT CORTICAL MUSCARINIC RECEPTORS
    FREEDMAN, SB
    HARLEY, EA
    IVERSEN, LL
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (02) : 437 - 445
  • [5] A NOVEL SERIES OF NONQUATERNARY OXADIAZOLES ACTING AS FULL AGONISTS AT MUSCARINIC RECEPTORS
    FREEDMAN, SB
    HARLEY, EA
    PATEL, S
    NEWBERRY, NR
    GILBERT, MJ
    MCKNIGHT, AT
    TANG, JK
    MAGUIRE, JJ
    MUDUNKOTUWA, NT
    BAKER, R
    STREET, LJ
    MACLEOD, AM
    SAUNDERS, J
    IVERSEN, LL
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (03) : 575 - 580
  • [6] MOTHERWELL WDS, 1978, PLUTO PROGRAM PLOTTI
  • [7] NO RESPONSE TO HIGH-DOSE MUSCARINIC AGONIST THERAPY IN ALZHEIMERS-DISEASE
    MOURADIAN, MM
    MOHR, E
    WILLIAMS, JA
    CHASE, TN
    [J]. NEUROLOGY, 1988, 38 (04) : 606 - 608
  • [8] PHARMACOLOGICAL DIFFERENCES BETWEEN 2 MUSCARINIC RESPONSES OF THE RAT SUPERIOR CERVICAL-GANGLION INVITRO
    NEWBERRY, NR
    PRIESTLEY, T
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) : 817 - 826
  • [9] THE CHOLINERGIC HYPOTHESIS - 10 YEARS ON
    PERRY, EK
    [J]. BRITISH MEDICAL BULLETIN, 1986, 42 (01) : 63 - 69
  • [10] A PHARMACOLOGICAL STUDY OF THE RESPONSES INDUCED BY MUSCARINIC AGONISTS ON THE ISOLATED SUPERIOR CERVICAL-GANGLION OF THE GUINEA-PIG
    ROBERTS, KE
    NEWBERRY, NR
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 186 (2-3) : 257 - 265